-
Endpoints News2 weeks ago
Biotech investors set to meet with key congressional panel
A group of biotech investors will meet with members of a congressional commission that’s been charged with keeping the US competitive in biotech and protecting national...
-
Fierce Biotech2 weeks ago
Medtronic, Biotronik heart hardware make strides in conduction system pacing
Medtronic and Biotronik both took steps forward this week with their pacemaker hardware designed to target newly emerging geography in the heart, for delivering electric signals...
-
Endpoints News2 weeks ago
Apnimed set to exit sleep disorder joint venture with Shionogi for $100M upfront
Shionogi is doubling down on its sleep disorder pipeline by buying out Apnimed’s half of their joint venture in the niche field. The Japanese pharma will...
-
Uncategorized2 weeks agoNovartis buys Synnovation’s PI3Kα inhibitors for $3 billion
Novartis has agreed a deal with Synnovation Therapeutics to acquire Pikavation Therapeutics and its portfolio of PI3Kα inhibitor programmes, including SNV4818. Pikavation is a wholly-owned subsidiary...
-
BioPharma Dive – AI / Data2 weeks agoHow former Acorda CEO Ron Cohen landed at a Parkinson’s cell therapy startup
Cohen says he looked at around two dozen companies since Acorda wound down. Oryon Cell Therapies, with its funding, data and “autologous” approach, stood out amongst...
-
Endpoints News2 weeks ago
Gilead bets $1.68B upfront on Ouro Medicines’ autoimmune program, with Galapagos expected to pitch in
Gilead Sciences is set to enter the T cell engager space in an unusual — perhaps even unprecedented — deal arrangement that involves the pharma budgeting...
-
Fierce Biotech2 weeks ago
Ocugen eye disease gene therapy hits ph. 2 targets but underwhelms investors
Full 12-month data from Ocugen’s phase 2 eye disease gene therapy show the therapy significantly reduces the size of lesions, though the treatment’s smaller effect compared...
-
Uncategorized2 weeks agoLaigo Bio raises $17m to advance oncology pipeline
Biotech company Laigo Bio has completed the second close of its seed financing round with an additional $5.5 million bringing the total investment to $17 million. Laigo will...
-
Uncategorized2 weeks agoNHS health data should be used for clinical trial recruitment, says ABPI
The UK has an opportunity to enhance its global competitiveness in the delivery of industry clinical trials by harnessing NHS health data to more efficiently recruit...
-
Endpoints News2 weeks ago
Merck partners with Flagship startup Quotient to search for genetic clues to IBD
Quotient Therapeutics, a startup studying how tiny genetic typos cause some cells to get sick but allow others to remain healthy, has struck a partnership with...
